Welcome to our dedicated page for Nexgel news (Ticker: NXGL), a resource for investors and traders seeking the latest updates and insights on Nexgel stock.
NEXGEL, Inc. (NASDAQ: NXGL) generates news across healthcare, consumer products, and capital markets through developments tied to its ultra-gentle, high-water-content hydrogel technology. The company regularly issues press releases on quarterly financial results, highlighting performance in its contract manufacturing segment and its portfolio of consumer-branded products in health, beauty, and OTC categories.
Investors following NXGL news will see updates on earnings announcements, including revenue trends, gross margin, operating expenses, and non-GAAP metrics such as EBITDA and Adjusted EBITDA. Management commentary often discusses demand for branded products, new contract manufacturing agreements, and the impact of partnerships with consumer healthcare companies.
NEXGEL’s news flow also covers strategic and corporate actions. Recent items include the spin-off of select drug delivery application assets into NexGelRx, with NEXGEL retaining a royalty interest, an equity stake, and exclusive hydrogel manufacturing rights. Additional releases have described expanded partnerships, such as the agreement with STADA Arzneimittel AG involving non-dilutive capital to support product launches and marketing efforts, as well as financing transactions like registered direct offerings and concurrent private placements.
Governance and leadership developments are another recurring news theme. NEXGEL has announced board appointments, conference presentations at investor events, and changes in senior finance roles through its press releases and associated SEC filings. Readers of this NXGL news page can review these updates in one place, including information on special meetings of stockholders, strategic advisors to NexGelRx, and other events that shape the company’s direction.
By monitoring the NXGL news feed, market participants can track how NEXGEL’s hydrogel-focused business, partnerships, financings, and governance decisions evolve over time, using official company communications as a primary source.
NEXGEL (NASDAQ: NXGL, NXGLW) has launched a partnership with Partners for World Health to provide humanitarian support in Ukraine. For every two boxes of SilverSeal® purchased, one will be donated to those in need. In June, 458 boxes were donated, equating to 1,832 healing patches. CEO Adam Levy emphasized the importance of treating skin injuries in crisis zones. The initiative addresses urgent medical needs amid ongoing conflict, aiming to deliver essential supplies through various shipping methods.
NEXGEL, Inc. (NASDAQ: NXGL) reported a 48% year-over-year revenue increase to $396 thousand for Q1 2022, driven by new product launches in its consumer segment. The company introduced two new OTC products: the MEDAGEL ClearComfort Hydrogel Patch and the MEDAGEL Bug Bite Relief Patch. Gross loss improved to $22 thousand from $42 thousand last year, although operating expenses rose to $790 thousand. Cash reserves decreased to $10.5 million due to principal payments on notes payable. The company forecasts continued revenue growth.
NEXGEL, a provider of high-water-content hydrogel products, will announce its first quarter 2022 financial and operating results on May 12, 2022, after market closure. A conference call is scheduled for 4:30 PM/ET on the same day to discuss these results. The call can be accessed via toll-free numbers and will be webcast live, with an archive available for 90 days. The company specializes in skin-friendly hydrogels, developing over 200 combinations using natural ingredients for long-term wear with minimal irritation.
NEXGEL, a provider of high-water-content hydrogel products, announces CEO Adam Levy's participation at the Planet MicroCap Showcase 2022 from May 3-5, 2022, in Las Vegas. Levy's presentation is scheduled for May 4, 2022, at 10:30 AM PT, with a webcast accessible for those unable to attend. Interested investors can book 1x1 meetings during the conference. NEXGEL specializes in gentle skin patches utilizing over 200 formulations and has been developing hydrogels for over 20 years.
NexGel, Inc. (NASDAQ: NXGL), a leader in ultra-gentle hydrogel products, will participate in the Maxim Group 2022 Virtual Growth Conference from March 28-30, 2022. CEO Adam Levy's presentation will be available on-demand at the conference's start. Attendees can register to join here. With over two decades of experience, NexGel specializes in high-water-content hydrogels for healthcare and consumer use.
NEXGEL, a provider of hydrogel products, reported a significant 130% year-over-year revenue growth for 2021, totaling $1.55 million. The fourth quarter saw a revenue increase of 428%, amounting to $533 thousand.
The company completed a $14.2 million IPO and has a cash reserve of $13.35 million as of December 31, 2021, supporting future growth initiatives. Operating expenses rose to $2.58 million, primarily due to one-time costs from the IPO. Despite growth, NEXGEL reported an EBITDA loss of $2.27 million for the year.
NEXGEL, a provider of high-water-content hydrogel products, will report its fourth quarter and full year 2021 financial results on March 21, 2022, after market closure. The company will host a conference call at 4:30 p.m. ET the same day to discuss these results, which will be available for streaming via its Investor Relations website. NEXGEL is known for formulating gentle skin patches utilizing natural ingredients, with over 200 combinations developed over two decades.
NEXGEL, Inc. (NASDAQ: NXGL) launched its new MEDAGEL Bug Bite Relief Patch on February 15, 2022. These patches are designed to provide instant relief for insect bites, using NEXGEL's high-water-content hydrogel technology. Infused with Arnica flower and Lidocaine, the patches are skin-friendly, chemical-free, and latex-free. They stay securely in place without irritation upon removal. The product is now available for purchase on Amazon.com.
NEXGEL, a leader in high-water-content hydrogel products, announced the launch of its new MEDAGEL ClearComfort Hydrogel Patch on January 12, 2022. Designed to prevent and treat foot blisters, these patches utilize advanced hydrogel technology to provide cushioning and protection against friction without leaving sticky residues. Available in customizable shapes, they cater to various footwear needs. CEO Adam Levy emphasized the product's ability to enhance comfort while addressing a common issue faced by consumers globally. The patches can be purchased on Amazon.com.
NEXGEL, a manufacturer of high-water-content hydrogels, provided a year-in-review for 2021, highlighting significant investments in its cGMP facility and the establishment of a robust executive and marketing team. NEXGEL focuses on three business segments: Consumer products like MedaGel and LumaGel, a Custom and White Label strategy for OTC brands, and Medical Devices like the NEXDrape. As of December 31, 2021, the company had 5.6 million shares outstanding and $13.3 million in cash, following a successful IPO that raised $14.2 million.